You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
Plaque psoriasis,TALTZ is indicated for the treatment of adult patients with moderate-to-severe plaque
psoriasis who are candidates for systemic therapy or phototherapy.,Psoriatic arthritis,TALTZ is indicated for the treatment of active psoriatic arthritis in adult patients who have
responded inadequately, or who are intolerant, to previous DMARD therapy.
TALTZ may be used as monotherapy or in combination with a conventional DMARD (e.g.
methotrexate).,Axial spondyloarthritis,Ankylosing Spondylitis (Radiographic Axial Spondyloarthritis),TALTZ is indicated for the treatment of active ankylosing spondylitis in adult patients.,Non-radiographic axial spondyloarthritis,TALTZ is indicated for the treatment of adult patients with active non-radiographic axial
spondyloarthritis with objective signs of inflammation as indicated by elevated C-reactive
protein (CRP) and/or MRI evidence, who have responded inadequately to, or are intolerant
to, nonsteroidal anti-inflammatory drugs (NSAIDs).
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
This medicine is under additional monitoring as it is new or being used in a different way. You can help identify new safety information by reporting any side effects you may get.
Plaque psoriasis,TALTZ is indicated for the treatment of adult patients with moderate-to-severe plaque
psoriasis who are candidates for systemic therapy or phototherapy.,Psoriatic arthritis,TALTZ is indicated for the treatment of active psoriatic arthritis in adult patients who have
responded inadequately, or who are intolerant, to previous DMARD therapy.
TALTZ may be used as monotherapy or in combination with a conventional DMARD (e.g.
methotrexate).,Axial spondyloarthritis,Ankylosing Spondylitis (Radiographic Axial Spondyloarthritis),TALTZ is indicated for the treatment of active ankylosing spondylitis in adult patients.,Non-radiographic axial spondyloarthritis,TALTZ is indicated for the treatment of adult patients with active non-radiographic axial
spondyloarthritis with objective signs of inflammation as indicated by elevated C-reactive
protein (CRP) and/or MRI evidence, who have responded inadequately to, or are intolerant
to, nonsteroidal anti-inflammatory drugs (NSAIDs).
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
This medicine is under additional monitoring as it is new or being used in a different way. You can help identify new safety information by reporting any side effects you may get.
Plaque psoriasis,TALTZ is indicated for the treatment of adult patients with moderate-to-severe plaque
psoriasis who are candidates for systemic therapy or phototherapy.,Psoriatic arthritis,TALTZ is indicated for the treatment of active psoriatic arthritis in adult patients who have
responded inadequately, or who are intolerant, to previous DMARD therapy.
TALTZ may be used as monotherapy or in combination with a conventional DMARD (e.g.
methotrexate).,Axial spondyloarthritis,Ankylosing Spondylitis (Radiographic Axial Spondyloarthritis),TALTZ is indicated for the treatment of active ankylosing spondylitis in adult patients.,Non-radiographic axial spondyloarthritis,TALTZ is indicated for the treatment of adult patients with active non-radiographic axial
spondyloarthritis with objective signs of inflammation as indicated by elevated C-reactive
protein (CRP) and/or MRI evidence, who have responded inadequately to, or are intolerant
to, nonsteroidal anti-inflammatory drugs (NSAIDs).
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
This medicine is under additional monitoring as it is new or being used in a different way. You can help identify new safety information by reporting any side effects you may get.
Plaque psoriasis,TALTZ is indicated for the treatment of adult patients with moderate-to-severe plaque
psoriasis who are candidates for systemic therapy or phototherapy.,Psoriatic arthritis,TALTZ is indicated for the treatment of active psoriatic arthritis in adult patients who have
responded inadequately, or who are intolerant, to previous DMARD therapy.
TALTZ may be used as monotherapy or in combination with a conventional DMARD (e.g.
methotrexate).,Axial spondyloarthritis,Ankylosing Spondylitis (Radiographic Axial Spondyloarthritis),TALTZ is indicated for the treatment of active ankylosing spondylitis in adult patients.,Non-radiographic axial spondyloarthritis,TALTZ is indicated for the treatment of adult patients with active non-radiographic axial
spondyloarthritis with objective signs of inflammation as indicated by elevated C-reactive
protein (CRP) and/or MRI evidence, who have responded inadequately to, or are intolerant
to, nonsteroidal anti-inflammatory drugs (NSAIDs).
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
This medicine is under additional monitoring as it is new or being used in a different way. You can help identify new safety information by reporting any side effects you may get.
Plaque psoriasis,TALTZ is indicated for the treatment of adult patients with moderate-to-severe plaque
psoriasis who are candidates for systemic therapy or phototherapy.,Psoriatic arthritis,TALTZ is indicated for the treatment of active psoriatic arthritis in adult patients who have
responded inadequately, or who are intolerant, to previous DMARD therapy.
TALTZ may be used as monotherapy or in combination with a conventional DMARD (e.g.
methotrexate).,Axial spondyloarthritis,Ankylosing Spondylitis (Radiographic Axial Spondyloarthritis),TALTZ is indicated for the treatment of active ankylosing spondylitis in adult patients.,Non-radiographic axial spondyloarthritis,TALTZ is indicated for the treatment of adult patients with active non-radiographic axial
spondyloarthritis with objective signs of inflammation as indicated by elevated C-reactive
protein (CRP) and/or MRI evidence, who have responded inadequately to, or are intolerant
to, nonsteroidal anti-inflammatory drugs (NSAIDs).
This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on December, 1 2024. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
This medicine is under additional monitoring as it is new or being used in a different way. You can help identify new safety information by reporting any side effects you may get.
Plaque psoriasis,TALTZ is indicated for the treatment of adult patients with moderate-to-severe plaque
psoriasis who are candidates for systemic therapy or phototherapy.,Psoriatic arthritis,TALTZ is indicated for the treatment of active psoriatic arthritis in adult patients who have
responded inadequately, or who are intolerant, to previous DMARD therapy.
TALTZ may be used as monotherapy or in combination with a conventional DMARD (e.g.
methotrexate).,Axial spondyloarthritis,Ankylosing Spondylitis (Radiographic Axial Spondyloarthritis),TALTZ is indicated for the treatment of active ankylosing spondylitis in adult patients.,Non-radiographic axial spondyloarthritis,TALTZ is indicated for the treatment of adult patients with active non-radiographic axial
spondyloarthritis with objective signs of inflammation as indicated by elevated C-reactive
protein (CRP) and/or MRI evidence, who have responded inadequately to, or are intolerant
to, nonsteroidal anti-inflammatory drugs (NSAIDs).
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
This medicine is under additional monitoring as it is new or being used in a different way. You can help identify new safety information by reporting any side effects you may get.
Government Accredited with over 140 information partners
We are a government-funded service, providing quality, approved health information and advice
Healthdirect Australia acknowledges the Traditional Owners of Country throughout Australia and their continuing
connection to land, sea and community. We pay our respects to the Traditional Owners and to Elders both past and
present.
